BostonGene and ImmunoGenesis Partner to Advance Precision Immunotherapy

BostonGene and ImmunoGenesis have announced a strategic collaboration to accelerate the development of IMGS-001, a next-generation immunotherapy targeting PD-L1 and PD-L2. By leveraging AI-driven multiomics and spatial biology, the partnership aims to better understand tumor biology, improve patient selection, and overcome resistance to existing immunotherapies.

Read more: https://bostongene.com/news-an....d-publications/news/

BostonGene Showcases Breakthrough AI Innovations in Cancer Research at AACR 2026

BostonGene will present 13 abstracts at the American Association for Cancer Research Annual Meeting 2026, showcasing its advanced AI platform for drug discovery and precision oncology. The research focuses on improving patient stratification, identifying new biomarkers, and enhancing clinical trial outcomes through integrated multiomic data and AI-powered insights.

Read the full news to discover how BostonGene is shaping the future of AI in cancer research: https://bostongene.com/news-an....d-publications/news/

Advancing Cancer Care Through Multiomic Insights

Emerging research showcases how next-generation molecular profiling is helping uncover hidden treatment opportunities in patients with advanced cancers. By going beyond traditional testing methods, this approach enables the discovery of new therapeutic targets and broadens access to more personalized care options.

Read the full press release to learn more about these findings and their impact on the future of cancer treatment. https://bostongene.com/news-an....d-publications/news/

AI in Immuno Oncology Development

Artificial intelligence is transforming cancer research and drug development. BostonGene has partnered with Ottimo Pharma to accelerate development of a first in class immuno oncology therapy targeting PD1 and VEGFR2 pathways.

This collaboration uses advanced analytics and multiomic data to improve clinical development and precision medicine strategies.

Read more here:
https://bostongene.com/news-an....d-publications/news/

Artificial Intelligence Transforming Oncology Research

Artificial intelligence is rapidly reshaping cancer research and therapeutic development. BostonGene has announced a strategic collaboration with AstraZeneca to advance foundation model driven oncology development.


Read the complete collaboration announcement here:
https://bostongene.com/news-an....d-publications/news/